FDA Panel Recommends Chantix Psychiatric Warnings Remain in Black Box
A panel of FDA advisors has voted to keep a black box suidice warning on the smoking cessation drug Chantix.
Tag Archives: Chantix
-
-
Chantix Black Box Warning on Psychiatric Side Effects Should Remain: FDA Reviewers
FDA reviewers say there is insufficient evidence to merit removing a warning from Chantix that alerts users to the risks of suicidal tendencies and violent urges.
-
Chantix Warning Concerns Continue, Even As Lawsuit MDL Shuts Down
A group of nonprofits are calling for the FDA to strengthen label warnings on Chantix before a hearing next week.
-
Chantix Linked to More Thoughts of Suicide Than Any Other Drug: Report
A new report warns that the smoking cessation drug Chantix is still the number one drug linked to thoughts of suicide and self-injurious behavior, suggesting that the FDA should not…
-
Pfizer Wants Blackbox Chantix Suicide Warning Removed From Label
Pfizer wants a black box label warning removed from Chantix following studies which question whether the drug can increase the risk of suicide.
-
Smokers Relying on E-Cigarettes to Quit: Survey
A new survey finds that more smokers choose electronic cigarettes to try to quit smoking than any other device.
-
Chantix Side Effects Face New FDA Review
The FDA will review the side effects of Chantix and its label warnings at a meeting on October.
-
FDA Adverse Event Reporting More Accurate Than Once Thought: Study
A new study sheds more light on the accuracy of the FDA's adverse event reporting system, which is often denigrated for its unscientific structure.
-
Study Finds No Heart Risks with Chantix, Other Anti-Smoking Products
A new study challenges previous allegations that the smoking cessation drug Chantix can increase the risk of heart problems.
-
Anti-Smoking Drug Suicide Risks Questioned by New Study
Researchers found no evidence that side effects of the smoking cessation drugs Chantix, Wellbutrin or Zyban increase the risk of suicide in a new study.
